Vera Therapeutics, Inc.
VERA
$39.96
-$1.21-2.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 714.59M | 497.39M | 556.83M | 589.83M | 640.85M |
| Total Receivables | 3.29M | 3.36M | 4.20M | 3.59M | 3.77M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.47M | 9.42M | 8.70M | 10.87M | 5.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.54M | 1.15M | 1.62M | 1.79M | 1.38M |
| Total Current Assets | 728.88M | 511.31M | 571.35M | 606.08M | 651.22M |
|
|
|||||
| Total Current Assets | 728.88M | 511.31M | 571.35M | 606.08M | 651.22M |
| Net Property, Plant & Equipment | 3.30M | 3.19M | 3.62M | 3.98M | 4.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.55M | 3.00M | 3.55M | 114.00K | 131.00K |
| Total Assets | 734.73M | 517.50M | 578.53M | 610.17M | 655.68M |
|
|
|||||
| Total Accounts Payable | 21.90M | 17.95M | 13.16M | 9.26M | 7.67M |
| Total Accrued Expenses | 29.64M | 23.46M | 19.54M | 11.44M | 14.47M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 549.00K | 473.00K | 855.00K | 1.19M | 1.48M |
| Total Finance Division Other Current Liabilities | 1.37M | -- | -- | -- | 1.75M |
| Total Other Current Liabilities | 1.37M | -- | -- | -- | 1.75M |
| Total Current Liabilities | 53.46M | 41.88M | 33.55M | 21.89M | 25.37M |
|
|
|||||
| Total Current Liabilities | 53.46M | 41.88M | 33.55M | 21.89M | 25.37M |
| Long-Term Debt | 74.84M | 74.65M | 74.46M | 50.91M | 50.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.92M | 2.10M | 2.23M | 2.37M | 2.47M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 130.21M | 118.62M | 110.25M | 75.17M | 78.53M |
|
|
|||||
| Common Stock & APIC | 1.36B | 1.07B | 1.06B | 1.05B | 1.04B |
| Retained Earnings | -760.87M | -669.77M | -589.48M | -512.94M | -461.25M |
| Treasury Stock & Other | 786.00K | 881.00K | 527.00K | 654.00K | 393.00K |
| Total Common Equity | 604.52M | 398.88M | 468.28M | 535.00M | 577.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 604.52M | 398.88M | 468.28M | 535.00M | 577.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 604.52M | 398.88M | 468.28M | 535.00M | 577.16M |
|
|
|||||